technetium tc 99m sestamibi has been researched along with melphalan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andretta, C; Annunziata, G; Catalano, L; Fonti, R; Pace, L; Rotoli, B | 1 |
1 other study(ies) available for technetium tc 99m sestamibi and melphalan
| Article | Year |
|---|---|
99mTc-sestaMIBI scintigraphy in thalidomide-treated refractory or relapsed multiple myeloma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Marrow; Dexamethasone; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thalidomide; Tissue Distribution | 2003 |